Biology of Blood and Marrow Transplantation
Volume 17, Issue 1 , Pages 69-77 , January 2011

Exogenous Addition of Minor H Antigen HA-1+ Dendritic Cells to Skin Tissues Ex Vivo Causes Infiltration and Activation of HA-1-Specific Cytotoxic T Cells

  • Yeung-Hyen Kim

      Affiliations

    • Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands
    • ,
  • Florry A. Vyth-Dreese

      Affiliations

    • Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    • ,
  • Ellen Schrama

      Affiliations

    • Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands
    • ,
  • Stan Pavel

      Affiliations

    • Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands
    • ,
  • Ingeborg Bajema

      Affiliations

    • Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
    • ,
  • Els Goulmy

      Affiliations

    • Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands
    • ,
  • Eric Spierings

      Affiliations

    • Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands
    • Department of Immunology, University Medical Center Utrecht, Utrecht, The Netherlands
    • Corresponding Author InformationCorrespondence and reprint requests: Eric Spierings, PhD, Department of Immunology, University Medical Center Utrecht, P.O. Box 85500, 3508 GA Utrecht, The Netherlands.

Received 11 December 2009 ,Accepted 5 August 2010.

References 

  1. Goulmy E. Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol Rev. 1997;157:125–140
  2. Spierings E, Goulmy E. MiHAS in medicine and biology. In:  Mehra N editors. HLA System in Medicine and Biology. New Delhi, India: Jaypee Brothers Medical Publishers Ltd; 2009;
  3. de Bueger M, Bakker A, van Rood JJ, Goulmy E. Minor histocompatibility antigens, defined by graft-vs.-host disease-derived cytotoxic T lymphocytes, show variable expression on human skin cells. Eur J Immunol. 1991;21:2839–2844
  4. Hambach L, Spierings E, Goulmy E. Risk assessment in haematopoietic stem cell transplantation: minor histocompatibility antigens. Best Pract Res Clin Haematol. 2007;20:171–187
  5. Dickinson AM, Wang XN, Sviland L, et al. In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens. Nat Med. 2002;8:410–414
  6. Hambach L, Goulmy E. Immunotherapy of cancer through targeting of minor histocompatibility antigens. Curr Opin Immunol. 2005;17:202–210
  7. Goulmy E, Schipper R, Pool J, et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med. 1996;334:281–285
  8. Tseng LH, Lin MT, Hansen JA, et al. Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation. Blood. 1999;94:2911–2914
  9. Gallardo D, Arostegui JI, Balas A, et al. Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation. Br J Haematol. 2001;114:931–936
  10. Spellman S, Warden MB, Haagenson M, et al. Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants. Biol Blood Marrow Transplant. 2009;15:856–863
  11. Collin MP, Hart DN, Jackson GH, et al. The fate of human Langerhans cells in hematopoietic stem cell transplantation. J Exp Med. 2006;203:27–33
  12. Merad M, Hoffmann P, Ranheim E, et al. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat Med. 2004;10:510–517
  13. Verdijk RM, Mutis T, Esendam B, et al. Polyriboinosinic polyribocytidylic acid (poly(I: C)) induces stable maturation of functionally active human dendritic cells. J Immunol. 1999;163:57–61
  14. Garrone P, Neidhardt EM, Garcia E, Galibert L, Van KC, Banchereau J. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med. 1995;182:1265–1273
  15. Caux C, Massacrier C, Vanbervliet B, et al. Activation of human dendritic cells through CD40 cross-linking. J Exp Med. 1994;180:1263–1272
  16. Mommaas B, Kamp J, Drijfhout JW, et al. Identification of a novel HLA-B60-restricted T cell epitope of the minor histocompatibility antigen HA-1 Locus. J Immunol. 2002;169:3131–3136
  17. van Els CA, D’Amaro J, Pool J, et al. Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics. 1992;35:161–165
  18. Mutis T, Gillespie G, Schrama E, Falkenburg JH, Moss P, Goulmy E. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat Med. 1999;5:839–842
  19. Haanen JB, van Oijen MG, Tirion F, et al. In situ detection of virus- and tumor-specific T-cell immunity. Nat Med. 2000;6:1056–1060
  20. Spierings E, Drabbels J, Hendriks M, et al. A uniform genomic minor histocompatibility antigen typing methodology and database designed to facilitate clinical applications. PLoS ONE. 2006;1:e42
  21. Lerner KG, Kao GF, Storb R, Buckner CD, Clift RA, Thomas ED. Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc. 1974;6:367–371
  22. Vyth-Dreese FA, Kim YH, Dellemijn TA, et al. In situ visualization of antigen-specific T cells in cryopreserved human tissues. J Immunol Methods. 2006;310:78–85
  23. de Bueger MM, Bakker A, van Rood JJ, Van der Woude F, Goulmy E. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol. 1992;149:1788–1794
  24. Wilke M, Dolstra H, Maas F, et al. Quantification of the HA-1 gene product at the RNA level; relevance for immunotherapy of hematological malignancies. Hematol J. 2003;4:315–320
  25. Polakos NK, Cornejo JC, Murray DA, et al. Kupffer cell-dependent hepatitis occurs during influenza infection. Am J Pathol. 2006;168:1169–1178
  26. Smyth MJ. Fas ligand-mediated bystander lysis of syngeneic cells in response to an allogeneic stimulus. J Immunol. 1997;158:5765–5772
  27. Blanchard N, Lankar D, Faure F, et al. TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex. J Immunol. 2002;168:3235–3241
  28. Denzer K, van EM, Kleijmeer MJ, Jakobson E, de GC, Geuze HJ. Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface. J Immunol. 2000;165:1259–1265
  29. Nolte-‘t Hoen EN, Wagenaar-Hilbers JP, Peters PJ, Gadella BM, van EW, Wauben MH. Uptake of membrane molecules from T cells endows antigen-presenting cells with novel functional properties. Eur J Immunol. 2004;34:3115–3125
  30. Neijssen J, Herberts C, Drijfhout JW, Reits E, Janssen L, Neefjes J. Cross-presentation by intercellular peptide transfer through gap junctions. Nature. 2005;434:83–88

 Financial disclosure: See Acknowledgments on page 76.

PII: S1083-8791(10)00345-9

doi: 10.1016/j.bbmt.2010.08.006

Biology of Blood and Marrow Transplantation
Volume 17, Issue 1 , Pages 69-77 , January 2011

Article Tools

* Image Usage & Resolution